Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruilin Sun

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cell|October 5, 2024
Identifying specific functional roles for senescence across cell typesHuan Zhao, Zixin Liu, Hui Chen, et al.
Journal of Thoracic Disease|July 10, 2020
Expert consensus for diagnosis and treatment using medical thoracoscopy in ChinaFaguang Jin, Hongwu Wang, Qiang Li, et al.
Journal of Medical Virology|February 28, 2020
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosisZhengtu Li, Yongxiang Yi, Xiaomei Luo, et al.
Cell Stem Cell|February 10, 2021
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targetingXimeng Han, Zhenqian Zhang, Lingjuan He, et al.
Science China. Life Sciences|May 4, 2021
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, ChinaZhengtu Li, Yinhu Li, Ruilin Sun, et al.
Nature Medicine|November 14, 2017
Enhancing the precision of genetic lineage tracing using dual recombinasesLingjuan He, Yan Li, Yi Li, et al.
Eclinicalmedicine|April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, George Zhang, John Mao, et al.
National Science Review|October 22, 2021
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19Mingxing Huang, Man Li, Fei Xiao, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Cell|May 4, 2020
Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, ChinaJing Lu, Louis du Plessis, Zhe Liu, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell|October 5, 2024
Identifying specific functional roles for senescence across cell typesHuan Zhao, Zixin Liu, Hui Chen, et al.
Journal of Thoracic Disease|July 10, 2020
Expert consensus for diagnosis and treatment using medical thoracoscopy in ChinaFaguang Jin, Hongwu Wang, Qiang Li, et al.
Journal of Medical Virology|February 28, 2020
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosisZhengtu Li, Yongxiang Yi, Xiaomei Luo, et al.
Cell Stem Cell|February 10, 2021
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targetingXimeng Han, Zhenqian Zhang, Lingjuan He, et al.
Science China. Life Sciences|May 4, 2021
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, ChinaZhengtu Li, Yinhu Li, Ruilin Sun, et al.
Nature Medicine|November 14, 2017
Enhancing the precision of genetic lineage tracing using dual recombinasesLingjuan He, Yan Li, Yi Li, et al.
Eclinicalmedicine|April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, George Zhang, John Mao, et al.
National Science Review|October 22, 2021
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19Mingxing Huang, Man Li, Fei Xiao, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Cell|May 4, 2020
Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, ChinaJing Lu, Louis du Plessis, Zhe Liu, et al.
Pageof 8